Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,170 public trials 550 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex

NCT00001011

Conditions
AIDS-Related Complex, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
  • UCLA CARE Ctr Los Angeles, California, United States
  • Palo Alto Veterans Adm Med Ctr / Stanford Univ Palo Alto, California, United States
  • Univ of California / San Diego Treatment Ctr San Diego, California, United States
View all 40 locations
View Trial Details
Completed

The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS

NCT00000989

Conditions
Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, Blood-Borne Infections, +30 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Beth Israel Deaconess - East Campus A0102 CRS Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Ctr. New York, United States
  • Unc Aids Crs Chapel Hill, North Carolina, United States
View Trial Details
Completed

Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)

NCT01404312

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +17 more
Locations
  • University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program La Jolla, California, United States
  • University of Southern California CRS Los Angeles, California, United States
  • UCSD Antiviral Research Center CRS San Diego, California, United States
  • Ucsf Hiv/Aids Crs San Francisco, California, United States
View all 45 locations
View Trial Details
Completed

A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults

NCT00001031

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UAB AVEG Birmingham, Alabama, United States
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • Univ. of Rochester AVEG Rochester, New York, United States
  • Univ. of Rochester ACTG CRS Rochester, New York, United States
View Trial Details
Completed

A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult Volunteers

NCT00001055

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UAB AVEG Birmingham, Alabama, United States
  • JHU AVEG Baltimore, Maryland, United States
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • Univ. of Rochester AVEG Rochester, New York, United States
View Trial Details
Completed

A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine

NCT00000770

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Univ of Southern California / LA County USC Med Ctr Los Angeles, California, United States
  • Highland Gen Hosp / San Francisco Gen Hosp Oakland, California, United States
  • Summitt Med Ctr / San Francisco Gen Hosp Oakland, California, United States
View all 44 locations
View Trial Details
Completed

Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens

NCT00001091

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Univ of Alabama at Birmingham - Pediatric Birmingham, Alabama, United States
  • UCSD Med Ctr / Pediatrics / Clinical Sciences La Jolla, California, United States
  • Long Beach Memorial (Pediatric) Long Beach, California, United States
  • Children's Hosp of Los Angeles/UCLA Med Ctr Los Angeles, California, United States
View all 55 locations
View Trial Details
Completed

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults

NCT00001096

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • JHU AVEG Baltimore, Maryland, United States
  • Univ. of Rochester AVEG Rochester, New York, United States
  • Vanderbilt Univ. Hosp. AVEG Nashville, Tennessee, United States
  • UW - Seattle AVEG Seattle, Washington, United States
View Trial Details

Related conditions